Skip to content
Just-Evotec Biologics
Just-Evotec BiologicsJust-Evotec Biologics
  • About
    • Our Story
    • Leadership
    • Partnership
  • GMP MANUFACTURING
  • Solutions
    • J.DESIGN
      • Humanoid Antibody Library (J.HAL)
      • GMP Manufacturing (J.POD)
  • News & Insights
    • Events
    • Press
    • Publications
      • Drug Discovery Update (DDup) journal
      • Technological insights
      • Scientific journals
      • Trade journals
    • Posters
    • Webinars
    • White Papers & Application Notes
  • Careers
  • Contact
  • Evotec
Search:
  • About
    • Our Story
    • Leadership
    • Partnership
  • GMP MANUFACTURING
  • Solutions
    • J.DESIGN
      • Humanoid Antibody Library (J.HAL)
      • GMP Manufacturing (J.POD)
  • News & Insights
    • Events
    • Press
    • Publications
      • Drug Discovery Update (DDup) journal
      • Technological insights
      • Scientific journals
      • Trade journals
    • Posters
    • Webinars
    • White Papers & Application Notes
  • Careers
  • Contact
  • Evotec

Category Archives: Press Release

Just – Evotec Biologics’ J.POD® wins CPhI Pharma Award 2022 for Manufacturing Technology and Equipment

Press ReleaseNovember 2, 2022

Just–Evotec Biologics has been awarded for its flexible cGMP biomanufacturing plant J.POD. The CPhI Award for Manufacturing Technology and Equipment honors innovation in technologies, products,…

Learn more

Just – Evotec Biologics awarded contract from U.S. Department of Defense under accelerated antibodies program

Press ReleaseSeptember 20, 2022

Just–Evotec Biologics will support the DOD with rapid, cost-efficient development of safe, efficacious anti-plague mabs. Evotec will provide pre-clinical and clinical trial services.

Learn more

Evotec initiates ground-breaking for new biologics facility J.POD® Toulouse, France (EU)

Press ReleaseSeptember 19, 2022

J.POD® Toulouse, France (EU) Brings a disruptive, flexibly scalable biologics manufacturing technology to the region. The manufacturing facility is expected to be operational in H2…

Learn more

Just–Evotec Biologics and Alpine Immune Sciences expand partnership for commercial process development of ALPN-303

Press ReleaseAugust 10, 2022

Just–Evotec Biologics will apply its fully integrated technology platform to develop an optimized commercial process for ALPN-303, a dual BAFF/APRIL inhibitor for systemic lupus erythematosus…

Learn more

Evotec receives € 7.5 m grant for development of COVID-19 therapeutic

Press ReleaseJanuary 3, 2022

Under the € 7.5 m grant, Evotec will use clinical material manufactured within its Just – Evotec Biologics manufacturing platform to initiate the clinical development…

Learn more

Just – Evotec Biologics Opens J.POD® 1 US in Redmond, Washington

Press ReleaseAugust 11, 2021

J.POD® 1 US provides uniquely flexible cGMP manufacturing of kilograms to metric tons of biologics therapeutics J.POD facility expands Just – Evotec Biologics’ capabilities into commercial…

Learn more

Evotec Accelerates Access to Biologic Therapeutics with Initiation of Manufacturing Facility in Toulouse

Press ReleaseApril 20, 2021

J.POD® 2 EU biomanufacturing will play a key role in addressing the need for therapeutic antibodies, including those related to infectious diseases such as COVID-19

Learn more

G-CON Manufacturing and Just – Evotec Biologics Complete the Installation of Cleanroom PODs® for the First J.POD®  Facility in North America

Press ReleaseMarch 16, 2021

Just – Evotec Biologics’ Redmond, Washington site offers true meaning to “Facility of the Future” with flexible and podular manufacturing of clinical and commercial-stage biologics.…

Learn more

Just – Evotec Biologics Expands Contract  With Department of Defense For Manufacturing of Monoclonal Antibodies

Press ReleaseJanuary 27, 2021

Just – Evotec Biologics will manufacture anti-SARS-CoV-2 and other antibodies at its J.POD® manufacturing facility. Access to manufacturing capacity over a period of 7 years

Learn more

Evotec Partners With Alloy Therapeutics  to Expand its Antibody Discovery Platform

Press ReleaseDecember 21, 2020

Evotec gains access to Alloy Therapeutics’ ATX-Gx™ humanised mouse platform for biologics discovery Partnership leverages complementary strengths of in silico, in vitro and in vivo…

Learn more

Just – Evotec Biologics Receives Grant To Enable An Antibody Product For The Prevention Of COVID-19

Press ReleaseOctober 19, 2020

Just – Evotec Biologics receives grant for COVID-19 monoclonal antibody optimisation and cell line development from the COVID-19 therapeutics accelerator Grant enables the optimisation of…

Learn more

Just – Evotec Biologics to Produce Monoclonal Antibody Products Against COVID-19 for The Department of Defense

Press ReleaseJuly 22, 2020

Just – Evotec Biologics to provide process development and manufacturing of monoclonal antibody

Learn more
→12→
innovation by design
North America
Just – Evotec Biologics, Inc.
401 Terry Avenue
Seattle, WA 98109
+1 206-651-5094
Europe + International
Just – Evotec Biologics
Business Development
info@evotec.com

Find us on:

Twitter page opens in new windowLinkedin page opens in new windowMail page opens in new window
© 2023 Just – Evotec Biologics
  • Contact
  • Imprint
  • Privacy Policy
  • Legal notice
footer menu
Go to Top
  • Ask an expert
  • Tweet
  • Share
  • Email
  • Scroll to top
  • Ask an expert
  • Twitter
  • Linkedin
  • Email
  • Whatsapp